Skip to main content
Premium Trial:

Request an Annual Quote

Arrayjet: Joe Keegan, Alan Faichney

Joe Keegan has been appointed non-executive chairman of Arrayjet, an Edinburgh, UK-based provider of liquid handling and bioprinting products for life sciences. Keegan serves as chair of a number of other companies including Carterra, Halo Labs, and Fluidic Analytics. He is also a board member of Bio-Techne, Interpace Biosciences, and Nuclera Nucleics. Keegan holds a BA in chemistry from Boston University and a PhD in physical chemistry from Stanford University.

Keegan will replace Alan Faichney, who is stepping down after seven years in the role.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.